791061-65-9Relevant articles and documents
Novel and potent calcium-sensing receptor antagonists: Discovery of (5R)-N-[1-ethyl-1-(4-ethylphenyl)propyl]-2,7,7-trimethyl-5-phenyl-4,5,6, 7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide monotosylate (TAK-075) as an orally active bone anabolic agent
Yoshida, Masato,Mori, Akira,Morimoto, Shinji,Kotani, Etsuo,Oka, Masahiro,Notoya, Kohei,Makino, Haruhiko,Ono, Midori,Shirasaki, Mikio,Tada, Norio,Fujita, Hisashi,Ban, Junko,Ikeda, Yukihiro,Kawamoto, Tomohiro,Goto, Mika,Kimura, Hiroyuki,Baba, Atsuo,Yasuma, Tsuneo
, p. 1881 - 1894 (2011/05/05)
The calcium-sensing receptor antagonist (CaSR) has been recognized as a promising target of anabolic agents for treating osteoporosis. In the course of developing a new drug candidate for osteoporosis, we found tetrahydropyrazolopyrimidine derivative 1 to